PL2068891T3 - Kompozycja zawierająca składniki gastrolitów skorupiaków, węglan wapnia i jej zastosowanie - Google Patents

Kompozycja zawierająca składniki gastrolitów skorupiaków, węglan wapnia i jej zastosowanie

Info

Publication number
PL2068891T3
PL2068891T3 PL07827185T PL07827185T PL2068891T3 PL 2068891 T3 PL2068891 T3 PL 2068891T3 PL 07827185 T PL07827185 T PL 07827185T PL 07827185 T PL07827185 T PL 07827185T PL 2068891 T3 PL2068891 T3 PL 2068891T3
Authority
PL
Poland
Prior art keywords
composition
calcium carbonate
components
crustacean gastrolith
crustacean
Prior art date
Application number
PL07827185T
Other languages
English (en)
Inventor
Yossi Ben
Amir Sagi
Original Assignee
Ben Gurion Univ Of The Negev Research And Development Authority
Yossi Ben
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ben Gurion Univ Of The Negev Research And Development Authority, Yossi Ben filed Critical Ben Gurion Univ Of The Negev Research And Development Authority
Publication of PL2068891T3 publication Critical patent/PL2068891T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Psychology (AREA)
  • Oncology (AREA)
PL07827185T 2006-10-05 2007-10-07 Kompozycja zawierająca składniki gastrolitów skorupiaków, węglan wapnia i jej zastosowanie PL2068891T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL178495A IL178495A (en) 2006-10-05 2006-10-05 Use of cancerous gastric components or artificial calcium containing carbonate, chitin and polypeptide preparations to treat calcium metabolism-related or calcium-signaling conditions
EP07827185.5A EP2068891B1 (en) 2006-10-05 2007-10-07 Composition comprising crustacean gastrolith components, calcium carbonate and its use
PCT/IL2007/001211 WO2008041236A2 (en) 2006-10-05 2007-10-07 Composition comprising crustacean gastrolith components, calcium carbonate and its use

Publications (1)

Publication Number Publication Date
PL2068891T3 true PL2068891T3 (pl) 2014-03-31

Family

ID=39153987

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07827185T PL2068891T3 (pl) 2006-10-05 2007-10-07 Kompozycja zawierająca składniki gastrolitów skorupiaków, węglan wapnia i jej zastosowanie

Country Status (14)

Country Link
US (2) US20100098774A1 (pl)
EP (1) EP2068891B1 (pl)
JP (1) JP2010505818A (pl)
CN (1) CN101563091A (pl)
AU (1) AU2007303786B2 (pl)
CA (1) CA2665141C (pl)
CY (1) CY1114930T1 (pl)
DK (1) DK2068891T3 (pl)
ES (1) ES2439741T3 (pl)
IL (1) IL178495A (pl)
PL (1) PL2068891T3 (pl)
PT (1) PT2068891E (pl)
SI (1) SI2068891T1 (pl)
WO (1) WO2008041236A2 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110121351A (zh) * 2016-10-25 2019-08-13 艾玛菲克有限公司 用于治疗白血病的无定形碳酸钙

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8257750B2 (en) * 1999-04-30 2012-09-04 Kibow Biotech, Inc. Calcium carbonate compositions for preventing or treating hyperphosphatemia
ES2393041T3 (es) * 2007-10-22 2012-12-18 Amorphical Ltd. Carbonato de calcio amorfo estable que comprende aminoácidos fosforilados
ES2831699T3 (es) * 2011-12-13 2021-06-09 Amorphical Ltd Un carbonato de calcio morfo para el tratamiento de la mala absorción de calcio y los trastornos metabólicos óseos
JP6263181B2 (ja) 2012-08-07 2018-01-17 アモーフィカル リミテッド． 安定化させた非晶質炭酸カルシウムの製造方法
WO2014122658A1 (en) * 2013-02-11 2014-08-14 Amorphical Ltd. Amorphous calcium carbonate for accelerated bone growth
CN103417635B (zh) * 2013-08-15 2015-05-20 张荣惠 接骨药
EP3174828B1 (en) 2014-07-31 2026-03-25 Amorphical Ltd. Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate
WO2016193982A1 (en) 2015-06-04 2016-12-08 Amorphical Ltd. Amorphous calcium carbonate stabilized with polyphosphates or bisphosphonates
US12121538B2 (en) 2015-06-04 2024-10-22 Amorphical Ltd. Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
WO2017102710A1 (en) * 2015-12-14 2017-06-22 Nestec S.A. Nutritional composition and infant formula for promoting myelination of the brain
AU2016374162A1 (en) * 2015-12-14 2018-04-19 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
WO2017125918A1 (en) * 2016-01-18 2017-07-27 Amorphical Ltd. Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions
CN108778295A (zh) 2016-01-18 2018-11-09 艾玛菲克有限公司 作为细胞培养基补充剂的稳定的无定形碳酸钙
WO2021014448A1 (en) 2019-07-23 2021-01-28 Amorphical Ltd Amorphous calcium carbonate for improving athletic performance

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237147A (en) 1974-01-04 1980-12-02 Monsanto Company Stabilized amorphous calcium carbonate
US4199496A (en) * 1974-09-05 1980-04-22 Johnson Edwin L Process for the recovery of chemicals from the shells of crustacea
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
US20060165784A1 (en) * 1997-05-06 2006-07-27 Zhao Jin R Calcium supplement
US20030077604A1 (en) * 2000-10-27 2003-04-24 Yongming Sun Compositions and methods relating to breast specific genes and proteins
JP2002205947A (ja) * 2000-12-11 2002-07-23 Chafflose Corporation 水虫治療薬
CN1543338B (zh) * 2001-08-16 2010-06-16 Cmp医疗有限公司 壳多糖微粒及其医疗用途
JP2004081739A (ja) * 2002-08-29 2004-03-18 Mitsuru Akashi ハイドロキシアパタイト−ポリマー複合材料の止血用組成物
US20070207198A1 (en) * 2003-09-17 2007-09-06 Beijing Sino-Hong Kong Dafu Science & Technology Of Biowave Co., Ltd. Use Of N-Acety1-D-Glucosamine In The Manufacture Of Medicaments For Anti-Tumors And Anti-Metastasis
JP5614916B2 (ja) * 2004-05-26 2014-10-29 ベン−グリオン ユニバーシティー オブ ザ ネゲヴ，リサーチ アンド ディベロップメント オーソリティー 安定な非結晶質炭酸カルシウムを含む経口投与可能な組成物
AU2005296271A1 (en) * 2004-10-15 2006-04-27 University Of Tennessee Research Foundation Methods for inducing apoptosis in adipocytes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110121351A (zh) * 2016-10-25 2019-08-13 艾玛菲克有限公司 用于治疗白血病的无定形碳酸钙

Also Published As

Publication number Publication date
US20130122117A1 (en) 2013-05-16
CA2665141C (en) 2015-03-24
CY1114930T1 (el) 2016-12-14
PT2068891E (pt) 2013-12-27
EP2068891B1 (en) 2013-09-25
ES2439741T3 (es) 2014-01-24
WO2008041236A3 (en) 2009-05-14
EP2068891A2 (en) 2009-06-17
AU2007303786B2 (en) 2012-07-26
US8728533B2 (en) 2014-05-20
WO2008041236A2 (en) 2008-04-10
AU2007303786A1 (en) 2008-04-10
CA2665141A1 (en) 2008-04-10
IL178495A0 (en) 2007-02-11
DK2068891T3 (da) 2014-01-13
IL178495A (en) 2014-12-31
JP2010505818A (ja) 2010-02-25
US20100098774A1 (en) 2010-04-22
CN101563091A (zh) 2009-10-21
SI2068891T1 (sl) 2014-02-28

Similar Documents

Publication Publication Date Title
SI2068891T1 (sl) Sestavek, ki obsega gastrolitne komponente rakov, kalcijev karbonat, in njegova uporaba
IL230759A0 (en) Converted acyl anilide, the pharmaceutical composition containing it and its uses
GB2457189B (en) Multicasting push-to-media content
EP1994928A4 (en) ANTIMICROBIAL AGENT AND ANTIMICROBIAL COMPOSITION
ZA200901132B (en) Human GLP-1 mimetibodies, compositions, methods and uses
IL194899A0 (en) Amino-ethyl-amino-aryl (aeaa) compounds and their use
GB0601143D0 (en) Uses, methods and compositions
IL197431A0 (en) Food composition
EP1994933A4 (en) AQUEOUS COMPOSITION
GB0621160D0 (en) Compounds and uses thereof
EP2124908A4 (en) CONNECTIONS AND ITS USE
GB0819432D0 (en) Compound, composition and use
EP2120563A4 (en) CONNECTIONS AND ITS USES
ZA200903304B (en) Food composition
EP1874141A4 (en) CALCIUM AND MAGNESIUM COMPLEMENT COMPOSITION
PL2099862T3 (pl) Nowa kompozycja termoplastyczna i jej zastosowanie
GB0624565D0 (en) Veterinary composition
EP2099459A4 (en) COMPOUNDS AND USES THEREOF
ZA200803412B (en) Food composition
GB0508991D0 (en) Veterinary composition
EP2010141A4 (en) NUCLEOTIDE COMPOSITIONS HAVING HIGH DEPOSITS AND USES THEREOF
GB0607562D0 (en) Method, composition and use
GB0600336D0 (en) Composition and uses thereof
GB0506496D0 (en) Compound, composition and use
GB2444005B (en) Compound, composition and use